Alligator Bioscience AB (publ) (STO:ATORX)

Sweden · Delayed Price · Currency is SEK

0.2065

-0.0030 (-1.43%)

May 21, 2026, 12:42 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development in The Field of Immunotherapy	839.00K	57.72M	59.25M	36.00M	13.33M
Research and Development in The Field of Immunotherapy Growth	-98.55%	-2.58%	64.58%	170.14%	141.65%
Total	839.00K	57.72M	59.25M	36.00M	13.33M
Total Growth	-98.55%	-2.58%	64.58%	170.14%	141.65%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Finland	-	57.76M	58.11M	35.70M	-
Finland Growth	-	-0.60%	62.78%	-	-
Belgium	514.00K	-	-	-	-
Sweden	-	7.00K	-	-	3.52M
Europe	-	-	-	-	6.42M
Asia	-	-	-	-	2.09M
Asia Growth	-	-	-	-	-51.88%
Other	-	-	-	-	908.00K
Total	514.00K	57.77M	58.11M	35.70M	12.94M
Total Growth	-99.11%	-0.59%	62.78%	175.79%	197.40%

Source: S&P Global Market Intelligence.